Parkman Healthcare Partners LLC Reduces Stake in LifeStance Health Group, Inc. (NASDAQ:LFST)

Parkman Healthcare Partners LLC reduced its stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 38.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 277,471 shares of the company's stock after selling 172,529 shares during the quarter. Parkman Healthcare Partners LLC owned approximately 0.07% of LifeStance Health Group worth $2,045,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Nuveen Asset Management LLC raised its stake in LifeStance Health Group by 34.2% in the fourth quarter. Nuveen Asset Management LLC now owns 422,475 shares of the company's stock valued at $3,114,000 after buying an additional 107,695 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of LifeStance Health Group by 2.4% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company's stock worth $1,023,000 after purchasing an additional 3,305 shares during the last quarter. Janus Henderson Group PLC grew its holdings in LifeStance Health Group by 51.4% during the fourth quarter. Janus Henderson Group PLC now owns 59,500 shares of the company's stock worth $439,000 after acquiring an additional 20,200 shares during the period. D. E. Shaw & Co. Inc. acquired a new stake in LifeStance Health Group during the fourth quarter worth about $451,000. Finally, Deutsche Bank AG grew its holdings in LifeStance Health Group by 78.8% during the fourth quarter. Deutsche Bank AG now owns 120,163 shares of the company's stock worth $886,000 after acquiring an additional 52,970 shares during the period. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

LifeStance Health Group Trading Up 0.9%

Shares of LFST stock traded up $0.05 on Friday, hitting $5.84. The stock had a trading volume of 1,259,003 shares, compared to its average volume of 1,657,640. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The firm has a market capitalization of $2.27 billion, a P/E ratio of -22.46 and a beta of 1.30. LifeStance Health Group, Inc. has a 1 year low of $4.64 and a 1 year high of $8.61. The company's 50 day moving average price is $6.53 and its 200-day moving average price is $7.21.

Insider Activity at LifeStance Health Group

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the sale, the insider now owns 339,810 shares in the company, valued at $2,344,689. This represents a 5.25% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 3.20% of the company's stock.

Analyst Ratings Changes

LFST has been the subject of a number of recent analyst reports. William Blair restated an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. Canaccord Genuity Group started coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They set a "buy" rating and a $8.00 price objective on the stock. Finally, KeyCorp initiated coverage on LifeStance Health Group in a research note on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price objective on the stock. One analyst has rated the stock with a sell rating, one has assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $8.30.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.